Advanced Magnetics of Cambridge, MA, has joined with its Japanese marketing partner Eiken Chemical to launch AMI's Feridex MRI liver contrast agent in Japan. Eiken will market Feridex through its distributor Tanabe Seiyaku. Japan represents one of the
Advanced Magnetics of Cambridge, MA, has joined with its Japanese marketing partner Eiken Chemical to launch AMI's Feridex MRI liver contrast agent in Japan. Eiken will market Feridex through its distributor Tanabe Seiyaku. Japan represents one of the last major marketplaces to approve Feridex, according to Jerome Goldstein, chairman and CEO of Advanced Magnetics.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.